trial

Motivational Interviewing for Patients With Acute Psychosis

NCTId NCT05911529
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 28 (actual)
Sponsored by Psychiatric University Hospital, Zurich
Primary completion 2023-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
28 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-03-15
Primary completion
2023-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
motivational interviewingSupportive conversations

Sponsors

Psychiatric University Hospital, ZurichLead Sponsor

Investigators

1
Philipp Homan, MD PhDPrincipal Investigator

Sites

1 total
Zurich, Switzerland

Facts & assertions

4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2023-12-31
Status
COMPLETED
relationships
The graph out of here
drug
motivational interviewing
drug
Supportive conversations
drug
lead_sponsor
Psychiatric University Hospital, Zurich
company
indication
Treatment Adherence and Compliance
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Philipp Homan, MD PhD
person